Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Understanding the ideal retirement planning timeline is crucial for securing your future. Learn how to effectively plan your retirement.
13,883 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Crypto.com cuts around staff by about 12%, eliminating roughly 180 roles as it refocuses on AI-enabled enterprise ser...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
A prominent Trump-backed bitcoin mining venture reported a heavy Q1 loss, triggering a notable slide in its shares. T...
The Department of Homeland Security is requesting $7.5 million to develop wearable facial-recognition glasses for ICE...
Standard Chartered is moving to absorb Zodia Custody's crypto operations, extending its digital-asset platform. The d...
Jaguar (JAGX) 2025 earnings show a company shifting from product-driven revenue to licensing cash. This piece breaks ...
New York moves toward banning potassium bromate in flour, potentially altering crusts and prices for thousands of piz...
Former President Donald Trump publicly supports CFTC Chair Michael Selig's push to widen federal control over predict...
As PJM prepares a March 2027 framework decision on data-center connections and pricing, investors are weighing how ne...
Brussels unveils a broad tech sovereignty package aimed at building European alternatives to U.S. cloud services and ...